Chong Kun Dang Pharmaceutical Corp.
Simbol: 185750.KS
KSC
101200
KRWTržna cena danes
6.4696
Razmerje P/E
-0.0542
Razmerje PEG
1.29T
Kapaciteta MRK
- 0.01%
Donos DIV
Chong Kun Dang Pharmaceutical Corp. (185750-KS) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 977306.91 | 365065.3 | 155861.2 | 187332.6 | |||||||||||
balance-sheet.row.short-term-investments | 234574.58 | 145418.9 | 38444.3 | 55519.9 | |||||||||||
balance-sheet.row.net-receivables | 1166084.87 | 311468.6 | 287306.6 | 234703.7 | |||||||||||
balance-sheet.row.inventory | 1101639.04 | 261431.9 | 270081.5 | 224722.9 | |||||||||||
balance-sheet.row.other-current-assets | 9554.78 | 8606.1 | 365.5 | 20387.9 | |||||||||||
balance-sheet.row.total-current-assets | 3254585.6 | 946571.9 | 713614.8 | 667147.2 | |||||||||||
balance-sheet.row.property-plant-equipment-net | 1263852.99 | 319787.1 | 310697.4 | 298909.7 | |||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.intangible-assets | 176043.64 | 52527.1 | 26953 | 20805.5 | |||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 176043.64 | 52527.1 | 26953 | 20805.5 | |||||||||||
balance-sheet.row.long-term-investments | 110109.3 | 67179.1 | 5565.5 | -22146.7 | |||||||||||
balance-sheet.row.tax-assets | 35440.27 | 14213.2 | 6208.6 | 2350.3 | |||||||||||
balance-sheet.row.other-non-current-assets | 186897.57 | 2150.1 | 61843.5 | 79634.1 | |||||||||||
balance-sheet.row.total-non-current-assets | 1772343.77 | 455856.6 | 411268 | 379552.9 | |||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.total-assets | 5026929.37 | 1402428.4 | 1124882.8 | 1046700.1 | |||||||||||
balance-sheet.row.account-payables | 677227.23 | 183938.8 | 145436.3 | 129327.4 | |||||||||||
balance-sheet.row.short-term-debt | 615980.74 | 184767.4 | 124445.5 | 102091.4 | |||||||||||
balance-sheet.row.tax-payables | 130003.78 | 43938.2 | 29026.4 | 18701.1 | |||||||||||
balance-sheet.row.long-term-debt-total | 301223.13 | 30000 | 111292.6 | 134962.3 | |||||||||||
Deferred Revenue Non Current | 14490.66 | 1484.8 | 6438.3 | 5982 | |||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 21900.45 | - | - | - | |||||||||||
balance-sheet.row.other-current-liab | 286154.11 | 134996.6 | 98922.3 | 20691.5 | |||||||||||
balance-sheet.row.total-non-current-liabilities | 395681.85 | 75327.4 | 129380.9 | 160660.6 | |||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.capital-lease-obligations | 31147.98 | 4996.5 | 1694.2 | 3470.5 | |||||||||||
balance-sheet.row.total-liab | 2153650.5 | 586793.3 | 503594 | 480890.4 | |||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.common-stock | 125684.64 | 31421.2 | 29970.1 | 28565.2 | |||||||||||
balance-sheet.row.retained-earnings | 1554612.31 | 218102.4 | 376370.8 | 302106.6 | |||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 1404661.23 | 350829.8 | 276706.4 | 250156.9 | |||||||||||
balance-sheet.row.other-total-stockholders-equity | -210144.4 | 215341.1 | -60654.3 | -14818.7 | |||||||||||
balance-sheet.row.total-stockholders-equity | 2874813.78 | 815694.5 | 622393.1 | 566010 | |||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 5026929.37 | 1402428.4 | 1124882.8 | 1046700.1 | |||||||||||
balance-sheet.row.minority-interest | -1534.92 | -59.3 | -1104.3 | -200.3 | |||||||||||
balance-sheet.row.total-equity | 2873278.86 | 815635.2 | 621288.8 | 565809.6 | |||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 5026929.37 | - | - | - | |||||||||||
Total Investments | 344683.88 | 212598 | 44009.8 | 33373.2 | |||||||||||
balance-sheet.row.total-debt | 922200.38 | 219763.9 | 235738.1 | 237053.8 | |||||||||||
balance-sheet.row.net-debt | 179468.05 | 117.5 | 118321.2 | 105241.1 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 213740.93 | 212521.2 | 79977.8 | 42356.5 | |||||||||||
cash-flows.row.depreciation-and-amortization | 37007.96 | 36942.2 | 33597.7 | 27481.9 | |||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.change-in-working-capital | 29681.84 | 29681.8 | -77299.3 | -71568.7 | |||||||||||
cash-flows.row.account-receivables | -29559.69 | -29559.7 | -51435.9 | -6926 | |||||||||||
cash-flows.row.inventory | -5980.26 | -5980.3 | -54466.2 | -53770.6 | |||||||||||
cash-flows.row.account-payables | 38583.78 | 38583.8 | 15824.5 | -15597.8 | |||||||||||
cash-flows.row.other-working-capital | 26638.01 | 26638 | 12778.2 | 4725.7 | |||||||||||
cash-flows.row.other-non-cash-items | 37729.17 | 39014.7 | 31458.4 | 14634.2 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 318159.91 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -68806.05 | -68806 | -53064.7 | -51844.4 | |||||||||||
cash-flows.row.acquisitions-net | 20636.77 | 451.6 | 142.1 | -3448.7 | |||||||||||
cash-flows.row.purchases-of-investments | -192468.23 | -192468.2 | -57181.1 | -61266.4 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 89470.04 | 89470 | 44375.6 | 21934.7 | |||||||||||
cash-flows.row.other-investing-activites | -20145.43 | 39.8 | 347.8 | 3815.5 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -171312.9 | -171312.9 | -65380.3 | -90809.3 | |||||||||||
cash-flows.row.debt-repayment | -44714.6 | -22714.6 | -0.3 | -896.2 | |||||||||||
cash-flows.row.common-stock-issued | 0 | -3335.3 | 0 | 0 | |||||||||||
cash-flows.row.common-stock-repurchased | -6024.99 | -6025 | -1888.4 | -1935.3 | |||||||||||
cash-flows.row.dividends-paid | 0 | -11608.5 | -11238.8 | -10808.3 | |||||||||||
cash-flows.row.other-financing-activites | 18648.14 | -16.5 | -3212.4 | 98778.7 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -43699.98 | -43700 | -16339.8 | 85138.9 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -917.57 | -917.6 | -410.1 | 920.1 | |||||||||||
cash-flows.row.net-change-in-cash | 102229.45 | 102229.4 | -14395.8 | 8153.6 | |||||||||||
cash-flows.row.cash-at-end-of-period | 742732.33 | 219646.3 | 117416.9 | 131812.7 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 640502.88 | 117416.9 | 131812.7 | 123659.1 | |||||||||||
cash-flows.row.operating-cash-flow | 318159.91 | 318159.9 | 67734.5 | 12903.9 | |||||||||||
cash-flows.row.capital-expenditure | -68806.05 | -68806 | -53064.7 | -51844.4 | |||||||||||
cash-flows.row.free-cash-flow | 249353.86 | 249353.9 | 14669.8 | -38940.5 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1657673.31 | 1669404.4 | 1488344.7 | 1343559.4 | |||||||||||
income-statement-row.row.cost-of-revenue | 779200.12 | 1014059.9 | 945705.3 | 847741.1 | |||||||||||
income-statement-row.row.gross-profit | 878473.19 | 655344.5 | 542639.4 | 495818.3 | |||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.research-development | 104406.15 | - | - | - | |||||||||||
income-statement-row.row.selling-general-administrative | 199875.81 | - | - | - | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 80977.59 | - | - | - | |||||||||||
income-statement-row.row.other-expenses | -716317.4 | -11694.4 | 139957.4 | 135069 | |||||||||||
income-statement-row.row.operating-expenses | 249710.32 | 408657.6 | 432733.3 | 401059.6 | |||||||||||
income-statement-row.row.cost-and-expenses | 1222350.41 | 1422717.5 | 1378438.7 | 1248800.7 | |||||||||||
income-statement-row.row.interest-income | 4775.61 | 5789.3 | 2139 | 716.2 | |||||||||||
income-statement-row.row.interest-expense | 7001.12 | 9271 | 6846.9 | 4029.9 | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 80977.59 | - | - | - | |||||||||||
income-statement-row.row.total-other-income-expensenet | 1.88 | -5283.9 | -12741 | -14164.8 | |||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||
income-statement-row.row.other-operating-expenses | -716317.4 | -11694.4 | 139957.4 | 135069 | |||||||||||
income-statement-row.row.total-operating-expenses | 1.88 | -5283.9 | -12741 | -14164.8 | |||||||||||
income-statement-row.row.interest-expense | 7001.12 | 9271 | 6846.9 | 4029.9 | |||||||||||
income-statement-row.row.depreciation-and-amortization | 202519.12 | 36942.2 | 34919.3 | 18187.3 | |||||||||||
income-statement-row.row.ebitda-caps | 444402.06 | - | - | - | |||||||||||
income-statement-row.row.operating-income | 241882.93 | 246686.9 | 109906.1 | 94758.7 | |||||||||||
income-statement-row.row.income-before-tax | 241884.82 | 241403 | 97165.1 | 80593.9 | |||||||||||
income-statement-row.row.income-tax-expense | 39271.89 | 27995.7 | 17187.3 | 38237.4 | |||||||||||
income-statement-row.row.net-income | 201766.15 | 212521.2 | 80953.4 | 42720.4 |
Pogosto zastavljeno vprašanje
Kaj je Chong Kun Dang Pharmaceutical Corp. (185750.KS) skupna sredstva?
Chong Kun Dang Pharmaceutical Corp. (185750.KS) skupna sredstva so 1402428435512.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so 858061047502.000.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.530.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je 19599.181.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je 0.122.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so 0.146.
Kaj je Chong Kun Dang Pharmaceutical Corp. (185750.KS) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je 212521171440.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 219763880100.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 408657610015.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 219646348416.000.